0001819615-22-000038.txt : 20220209 0001819615-22-000038.hdr.sgml : 20220209 20220209171815 ACCESSION NUMBER: 0001819615-22-000038 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220209 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220209 DATE AS OF CHANGE: 20220209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clever Leaves Holdings Inc. CENTRAL INDEX KEY: 0001819615 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39820 FILM NUMBER: 22608271 BUSINESS ADDRESS: STREET 1: 6501 CONGRESS AVE STREET 2: SUITE 240 CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 646-880-4382 MAIL ADDRESS: STREET 1: 6501 CONGRESS AVE STREET 2: SUITE 240 CITY: BOCA RATON STATE: FL ZIP: 33487 8-K/A 1 clvr-20220209.htm 8-K/A clvr-20220209
0001819615TRUE
This Amendment No. 1 to the Current Report on Form 8-K (the “Current Report”) filed by Clever Leaves Holdings Inc. (the “Company” or “Clever Leaves”) with the Securities and Exchange Commission on February 9, 2022 (the “Original Form 8-K”) is being filed to:

•correct errors reported in the Original Form 8-K concerning the Company’s expected net loss ranges for the quarter and year ended December 31, 2021 and its actual net loss for the quarter and year ended December 31, 2020;

•to correct errors reported in the Original Form 8-K reconciling Adjusted EBITDA to the most directly comparable U.S. GAAP measure, net loss; and

•re-furnish Exhibit 99.1 (the “Exhibit”), which, as previously furnished, unintentionally omitted the non-GAAP reconciliation table.

No other changes have been made to the Original Form 8-K
00018196152022-02-092022-02-090001819615us-gaap:CommonStockMember2022-02-092022-02-090001819615us-gaap:WarrantMember2022-02-092022-02-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K/A
(AMENDMENT NO. 1)
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): February 9, 2022
 
Clever Leaves Holdings Inc.
(Exact name of registrant as specified in its charter)
 
British Columbia, Canada 001-39820 Not Applicable
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
6501 Congress Ave, Suite 240
Boca Raton, FL
 33487
(Address of principal executive offices) (Zip Code)

(561) 634-7430
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 Securities registered pursuant to Section 12(b) of the Act:
 
Title of each classTrading Symbol (s)Name of each exchange on which registered
Common shares without par valueCLVRThe Nasdaq Stock Market LLC
Warrants, each warrant exercisable for one common share at an exercise price of $11.50CLVRWThe Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 



Explanatory Note

This Amendment No. 1 to the Current Report on Form 8-K (the “Current Report”) filed by Clever Leaves Holdings Inc. (the “Company” or “Clever Leaves”) with the Securities and Exchange Commission on February 9, 2022 (the “Original Form 8-K”) is being filed to:

•correct errors reported in the Original Form 8-K concerning the Company’s expected net loss ranges for the quarter and year ended December 31, 2021 and its actual net loss for the quarter and year ended December 31, 2020;

•to correct errors reported in the Original Form 8-K reconciling Adjusted EBITDA to the most directly comparable U.S. GAAP measure, net loss; and

•re-furnish Exhibit 99.1 (the “Exhibit”), which, as previously furnished, unintentionally omitted the non-GAAP reconciliation table.

The information set forth in the Original Form 8-K is incorporated herein by reference and restated in part below. Except as stated in this Explanatory Note, this Current Report does not otherwise change or update the disclosure set forth in the Original Form 8-K and does not otherwise reflect events after the Original Form 8-K was filed. The items set forth below are the only items from the Original Form 8-K that are being amended.

Item 2.02 Results of Operations and Financial Condition.

On February 9, 2022, the Company issued a press release announcing certain preliminary unaudited financial results for the quarter and year ended December 31, 2021 and its preliminary outlook for 2022.

A copy of the press release issued by the Company on February 9, 2022 announcing the Company’s preliminary unaudited financial results and its preliminary outlook for 2022 is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

As disclosed in Item 2.02 above, on February 9, 2022, the Company issued a press release announcing certain preliminary unaudited financial results for the quarter and year ended December 31, 2021 and its preliminary outlook for 2022. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information set forth in Item 2.02, Item 7.01 and Item 9.01 of this Current Report on Form 8-K, including the related information set forth in the press release attached hereto as Exhibit 99.1 and incorporated by reference herein, is being “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section.

Item 8.01 Other Events.

Fourth Quarter 2021 Financial Estimates vs. Same Year-Ago Quarter
Net loss is expected to range between approximately $17.1 million and $17.5 million compared to $0.9 million.
Full Year 2021 Financial Estimates vs. 2020
•Net loss is expected to range between approximately $38.8 million and $39.2 million compared to $25.9 million.


The financial data presented above are preliminary unaudited estimates estimated ranges with respect to the Company’s fourth quarter and full year ended December 31, 2021 net loss based on currently available information. These estimates were prepared by management in good faith based upon internal reporting for the quarter and full year ended December 31, 2021. Although the Company has not identified any unusual or unique events or trends that occurred during the period which might materially affect these estimates, the financial close process and review are not yet complete and, as a result, the Company’s final results upon completion of its closing process may be outside the estimated ranges provided. The Company’s independent registered public accounting firm, BDO Canada LLP, has not audited, reviewed, compiled or performed any procedures on this preliminary financial data. You should not place undue reliance on this preliminary estimated financial information and should review the Company’s full financial results for the fourth quarter and full year ended December 31, 2021 when available. Clever Leaves expects to report its fourth quarter and full year ended December 31, 2021 results, and provide additional operational updates, in March 2022.









Non-GAAP Financial Measures

In this Current Report Clever Leaves refers to certain non-GAAP financial measures including Adjusted EBITDA. Adjusted EBITDA does not have a standardized meaning prescribed by GAAP and is therefore unlikely to be comparable to similar measures presented by other companies. Adjusted EBITDA is defined as income/loss from continuing operations before interest, taxes, depreciation, amortization, share-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt, gain/loss on remeasurement of warrant liability, and miscellaneous expenses. Adjusted EBITDA also excludes the impact of certain non-recurring items that are not directly attributable to the underlying operating performance. Clever Leaves considers Adjusted EBITDA to be a meaningful indicator of the performance of its core business. Adjusted EBITDA should neither be considered in isolation nor as a substitute for the financial measures prepared in accordance with U.S. GAAP. For a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure, see the relevant schedule with this Current Report.

Forward-Looking Statements

This Current Report includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “aim,” “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “evolve,” “expect,” “forecast,” “future,” “guidance,” “intend,” “may,” “opportunity,” “outlook,” “pipeline,” “plan,” “predict,” “potential,” “projected,” “seek,” “seem,” “should,” “will,” “would” and similar expressions (or the negative versions of such words or expressions) that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements as well as our outlook for 2021 are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Important factors that may affect actual results or the achievability of the Company’s expectations include, but are not limited to: (i) expectations with respect to future operating and financial performance and growth, including if or when Clever Leaves will become profitable; (ii) Clever Leaves’ ability to execute its business plans and strategy and to receive regulatory approvals; (iii) Clever Leaves’ ability to capitalize on expected market opportunities, including the timing and extent to which cannabis is legalized in various jurisdictions; (iv) global economic and business conditions; (v) geopolitical events, natural disasters, acts of God and pandemics, including the economic and operational disruptions and other effects of COVID-19 such as the global supply chain crisis, travel restrictions, delays or disruptions to physical shipments (including outright bans on imported products), delays in issuing licenses and permits, delays in hiring necessary personnel to carry out sales, cultivation and other tasks, and financial pressures upon Clever Leaves and its customers; (vi) regulatory developments in key markets for the company's products, including international regulatory agency coordination and increased quality standards imposed by certain health regulatory agencies, and failure to otherwise comply with laws and regulations; (vii) uncertainty with respect to the requirements applicable to certain cannabis products as well as the permissibility of sample shipments, and other risks and uncertainties; (viii) consumer, legislative, and regulatory sentiment or perception regarding Clever Leaves’ products; (ix) lack of regulatory approval and market acceptance of Clever Leaves’ new products; (x) the extent to which Clever Leaves’ is able to monetize its existing THC market quota within Colombia; (xi) demand for Clever Leaves’ products and Clever Leaves’ ability to meet demand for its products and negotiate agreements with existing and new customers; (xii) developing product enhancements and formulations with commercial value and appeal; (xiii) product liability claims exposure; (xiv) lack of a history and experience operating a business on a large scale and across multiple jurisdictions; (xv) limited experience operating as a public company; (xvi) changes in currency exchange rates and interest rates; (xvii) weather and agricultural conditions and their impact on the Company’s cultivation and construction plans, (xviii) Clever Leaves’ ability to hire and retain skilled personnel in the jurisdictions where it operates; (xix) Clever Leaves’ rapid growth, including growth in personnel; (xx) Clever Leaves’ ability to remediate a material weakness in its internal control cover financial reporting and to develop and maintain effective internal and disclosure controls; (xxi) potential litigation; (xxiii) access to additional financing; and (xxiv) completion of our construction initiatives on time and on budget. The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in Clever Leaves’ most recent filings with the SEC. All subsequent written and oral forward-looking statements concerning Clever Leaves and attributable to Clever Leaves or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Clever Leaves expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.













Adjusted EBITDA Reconciliation (Non-GAAP) Measure
Twelve months endedQuarter ended
Dec 31, (unaudited)Dec 31, (unaudited)
(In thousands of United States dollars)Lower RangeUpper RangeLower RangeUpper Range
Net Loss(38,800)(39,200)(17,100)(17,500)
Gain on remeasurement of warrant liability(16,900)(16,900)(11,500)(11,500)
Share-based compensation11,40011,4003,3003,300
Goodwill impairment15,50015,50015,50015,500
Depreciation & amortization2,4002,400600600
Interest expense, net4,3004,3001,9001,900
(Gain) / loss on extinguishment of debt(3,300)(3,300)100100
Foreign exchange loss1,3001,300100100
Other income, net(300)(300)(200)(200)
Adjusted EBITDA (Non-GAAP Measure)(24,400)(24,800)(7,300)(7,700)

Item 9.01. Financial Statements and Exhibits.









SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Clever Leaves Holdings Inc.
By:/s/ David M. Kastin
Name:David M. Kastin
Title:General Counsel and Corporate Secretary

Date: February 9, 2022
















 EX-99.1 2 clvr-q4x21prexannouncement.htm EX-99.1 Document
image_0.jpg


Clever Leaves Announces Preliminary Fourth Quarter and Full Year 2021 Results
and Introduces 2022 Outlook

Performance Delivers on 2021 Outlook and Provides Solid Foundation for 2022

2022 Outlook and Strategic Growth Objectives Reflect Ramping Commercialization Opportunities Within Core Global Markets

BOCA RATON, FL, February 9, 2022 – Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook.

Preliminary Unaudited Financial Results

Fourth Quarter 2021 Financial Estimates vs. Same Year-Ago Quarter:
•Revenue is expected to increase 25% to approximately $4.2 million compared to $3.3 million.
•Gross profit is expected to increase 5% to approximately $2.4 million compared to $2.3 million, with a gross margin of approximately 56.8% compared to 67.9%.
•Net loss is expected to range between approximately $17.1 million and $17.5 million compared to $0.9 million.
•Adjusted EBITDA (a non-GAAP number defined and reconciled herein) is expected to range between approximately $(7.3) million and $(7.7) million compared to $(6.3) million.
•At December 31, 2021, the Company’s cash, cash equivalents, and restricted cash are expected to be approximately $37 million compared to $79.5 million.
Full Year 2021 Financial Estimates vs. 2020:
•Revenue is expected to increase 27% to approximately $15.4 million compared to $12.1 million.
•Gross profit is expected to increase 28% to approximately $9.5 million compared to $7.4 million, with a gross margin of approximately 61.7% compared to 61.2%.
•Net loss is expected to range between approximately $38.8 million and $39.2 million compared to $25.9 million.
•Adjusted EBITDA is expected to range between approximately $(24.4) million and $(24.8) million compared to $(23.3) million.
“Our preliminary results demonstrate continued progress on our strategic objectives, providing a solid foundation for Clever Leaves in 2022,” said Kyle Detwiler, CEO of Clever Leaves. “We generated strong revenue growth year-over-year and maintained our prudent approach to cost management, which allowed us to drive continued margin benefits for the full year. We have executed on the milestone targets provided in our revised 2021 outlook, and I am proud of our team’s relentless dedication to sustaining production efficiencies and advancing our distribution efforts across key international markets.”

The financial data presented above are preliminary unaudited estimates (or, for certain metrics, estimated ranges) with respect to certain of the Company’s fourth quarter and full year ended December 31, 2021 results based on currently available information. These estimates were prepared by management in good faith based upon internal reporting for the quarter and full year ended December 31, 2021. Although the Company has not identified any unusual or unique events or trends that occurred during the period which might materially affect these estimates, the financial close process and review are not yet complete and, as a result, the Company’s final results upon completion of its closing process may vary from these estimates or be outside the estimated ranges provided. The Company’s independent registered public accounting firm, BDO Canada LLP, has not audited, reviewed, compiled or performed any procedures on this preliminary financial data. You should not place undue reliance on this preliminary estimated financial information and should review the Company’s full financial results for the fourth quarter and full year ended December 31, 2021 when available.
Clever Leaves expects to report its fourth quarter and full year ended December 31, 2021 results, and provide additional operational updates, in March 2022.
image_0.jpg

Preliminary 2022 Outlook and Strategic Growth Objectives

Following on the operational and commercial progress Clever Leaves has made throughout 2021, the Company expects full year 2022 revenue to range between $20 million and $25 million, with a gross margin of between 50% and 55%. This revenue range reflects an estimated increase in cannabinoid revenue of between two times and five times 2021 cannabinoid revenue. Clever Leaves also expects adjusted EBITDA to range between $(23) million and $(20) million. The Company expects approximately $2 million to $3 million of annual capital expenditures, representing an estimated 70% reduction compared to 2021.

In support of these full year financial targets, the Company has conducted a review of its operations to streamline the organization and reduce expenses in a manner that aims to minimize the commercial impact. The Company has already made several changes, including workforce reductions, elimination of non-core programs, and postponement of sales or product development associated with longer-lead time commercial opportunities or geographies. The Company continues to evaluate its cash resources and need for additional capital, while focusing on generating cash through reducing working capital. The Company believes it is positioned to benefit from the completion of the capital-intensive phase of its growth by focusing on gaining commercial contracts, and improving its margins.

As a result of this review, the Company has identified the following strategic growth objectives and key regions of focus for 2022:

•Australia: Capitalize on early traction with expansion of flower products and scale and secure additional extract sales agreements.
•Germany: Commence full commercial launch for the IQANNA flower brand, initiate sales of products through extract B2B partnerships, and activate import path for flower from our Portugal operation.
•Brazil: Activate sales agreements for products that have recently received regulatory approval and complete approval for other key products.
•Israel: Scale existing relationships for APIs and secure a large commercial-scale partnership for flower.
•United States: Commercially launch first CBD brand, JoySol.
•Colombia: Continue preparation for first flower sales, pending passage of final government resolutions.
Detwiler continued: “As we progress through 2022, we are working toward several commercial and regulatory milestones, which, if achieved, we expect will result in increased cannabinoid sales. Several regulatory or customer approval processes that were hampered by the pandemic now appear to be progressing. Having completed both construction and licensing on our Portugal cultivation expansion ahead of schedule in 2021, we are nearing completion on our capex cycle, which we believe positions us to maintain our disciplined approach to capital deployments. On the commercial front, our 2022 revenue expectations include the benefit from the cannabinoid product approvals we have obtained in Brazil. In 2022, we plan to continue our focus on ramping our existing supply partnerships and deepening our foothold within several international cannabis markets we believe have high potential.

To support our continued work on activating our commercial pipeline, we have identified six key strategic goals on which to focus our efforts in 2022. As of last month, we have already achieved progress on our first goal, having announced our entrance into the U.S. consumer CBD market with the launch of JoySol. In Germany, we continue to make progress towards commencing our full distribution of IQANNA following a successful soft launch of the product in the third quarter of 2021, and we are nearing several commercial and business development milestones with other B2B partnerships. We remain attentive to how regulatory standards evolve in the German market and across all of our core markets, particularly as we monitor product approvals in Brazil and the status of Colombia’s resolutions dictating the timing and regulations surrounding dried flower exports. In Brazil, after lengthy product registration work to comply with strict pharmaceutical product registration protocols, we have seen a few of our partners receive special marketing authorization for cannabis products, which is one of the last milestones to accomplish before a partner can move to commercial-scale orders.

In Australia and Israel, we plan to continue working to ramp our existing supply agreements and grow our presence within these markets. With the gradual progress we have made in each market over the past year, we seek to maintain close collaborations with our current supply partners and identify additional commercial opportunities. While our work to achieve Clever Leaves’ long-term vision remains ongoing, we believe our efforts to steadily execute on these objectives will continue to strengthen our commercial partnerships and overall presence within the global cannabinoid supply chain.”
image_0.jpg

For more information about our fourth-quarter and full year 2021 performance and 2022 outlook, please see our Investor Presentation, dated February 9, 2022, which is available on our website.

About Clever Leaves Holdings Inc.
Clever Leaves is a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade cannabinoid processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute - Invima, and Good Agricultural and Collecting Practices (GACP) Certification. Clever Leaves was granted a license in Portugal from Infarmed – the Portuguese health authority – which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes. In addition, the Portuguese operation was also granted by Control Union Certifications to be compliant with GACP and GAP from EMEA and WHO, as well as with CUMCS – G.A.P.

For more information, visit https://cleverleaves.com/en/home/ and follow Clever Leaves on Twitter and LinkedIn.
Non-GAAP Financial Measures
In this press release, Clever Leaves refers to certain non-GAAP financial measures including Adjusted EBITDA. Adjusted EBITDA does not have a standardized meaning prescribed by GAAP and is therefore unlikely to be comparable to similar measures presented by other companies. Adjusted EBITDA is defined as income/loss from continuing operations before interest, taxes, depreciation, amortization, share-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt, gain/loss on remeasurement of warrant liability, and miscellaneous expenses. Adjusted EBITDA also excludes the impact of certain non-recurring items that are not directly attributable to the underlying operating performance. Clever Leaves considers Adjusted EBITDA to be a meaningful indicator of the performance of its core business. Adjusted EBITDA should neither be considered in isolation nor as a substitute for the financial measures prepared in accordance with U.S. GAAP. For a reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP measure, see the relevant schedules provided with this press release. We have not reconciled forward-looking Adjusted EBITDA to its comparable GAAP financial measure because we could not produce the corresponding GAAP financial measure by the date of this press release without unreasonable effort.

Forward-Looking Statements
This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “aim,” “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “evolve,” “expect,” “forecast,” “future,” “guidance,” “intend,” “may,” “opportunity,” “outlook,” “pipeline,” “plan,” “predict,” “potential,” “projected,” “seek,” “seem,” “should,” “will,” “would” and similar expressions (or the negative versions of such words or expressions) that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements as well as our outlook for 2022 are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Important factors that may affect actual results or the achievability of the Company’s expectations include, but are not limited to: (i) expectations with respect to future operating and financial performance and growth, including if or when Clever Leaves will become profitable; (ii) Clever Leaves’ ability to execute its business plans and strategy (including its goals in its six key markets) and to receive regulatory approvals; (iii) Clever Leaves’ ability to capitalize on expected market opportunities, including the timing and extent to which cannabis is legalized in various jurisdictions; (iv) global economic and business conditions; (v) geopolitical events, natural disasters, acts of God and pandemics, including the economic and operational disruptions and
other effects of COVID-19 such as the global supply chain crisis, travel restrictions, delays or disruptions to physical shipments (including outright bans on imported products), delays in issuing licenses and permits, delays in hiring necessary personnel to carry out sales, cultivation and other tasks, and financial pressures upon Clever Leaves and its
image_0.jpg

customers; (vi) regulatory developments in key markets for the company's products, including international regulatory agency coordination and increased quality standards imposed by certain health regulatory agencies, and failure to otherwise comply with laws and regulations; (vii) uncertainty with respect to the requirements applicable to certain cannabis products as well as the permissibility of sample shipments, and other risks and uncertainties; (viii) consumer, legislative, and regulatory sentiment or perception regarding Clever Leaves’ products; (ix) lack of regulatory approval and market acceptance of Clever Leaves’ new products, which may impede our ability to successfully commercialize our CBD brand in the United States; (x) the extent to which Clever Leaves’ is able to monetize its existing THC market quota within Colombia; (xi) demand for Clever Leaves’ products and Clever Leaves’ ability to meet demand for its products and negotiate agreements with existing and new customers, including the sales agreements identified as a part of our 2022 strategic growth objectives; (xii) developing product enhancements and formulations with commercial value and appeal; (xiii) product liability claims exposure; (xiv) lack of a history and experience operating a business on a large scale and across multiple jurisdictions; (xv) limited experience operating as a public company; (xvi) changes in currency exchange rates and interest rates; (xvii) weather and agricultural conditions and their impact on the Company’s cultivation and construction plans, (xviii) Clever Leaves’ ability to hire and retain skilled personnel in the jurisdictions where it operates; (xix) Clever Leaves’ rapid growth, including growth in personnel; (xx) Clever Leaves’ ability to remediate a material weakness in its internal control cover financial reporting and to develop and maintain effective internal and disclosure controls; (xxi) potential litigation; (xxiii) access to additional financing; and (xxiv) completion of our construction initiatives on time and on budget. The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in Clever Leaves’ most recent filings with the SEC. All subsequent written and oral forward-looking statements concerning Clever Leaves and attributable to Clever Leaves or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Clever Leaves expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Clever Leaves Investor Inquiries:
Cody Slach or Jackie Keshner
Gateway Investor Relations
+1-949-574-3860
CLVR@gatewayir.com

Clever Leaves Press Contacts:
McKenna Miller
KCSA Strategic Communications
+1-347-487-6197
mmiller@kcsa.com

Diana Sigüenza
Strategic Communications Director
+57-310-236-8830
diana.siguenza@cleverleaves.com

Clever Leaves Commercial Inquiries:
Andrew Miller
Vice President Sales - EMEA, North America, and Asia-Pacific
+1-416-817-1336
andrew.miller@cleverleaves.com

image_0.jpg



Adjusted EBITDA Reconciliation (Non-GAAP) Measure
Twelve months endedQuarter ended
Dec 31, (unaudited)Dec 31, (unaudited)
(In thousands of United States dollars)Lower RangeUpper RangeLower RangeUpper Range
Net Loss(38,800)(39,200)(17,100)(17,500)
Gain on remeasurement of warrant liability(16,900)(16,900)(11,500)(11,500)
Share-based compensation11,40011,4003,3003,300
Goodwill impairment15,50015,50015,50015,500
Depreciation & amortization2,4002,400600600
Interest expense, net4,3004,3001,9001,900
(Gain) / loss on extinguishment of debt(3,300)(3,300)100100
Foreign exchange loss1,3001,300100100
Other income, net(300)(300)(200)(200)
Adjusted EBITDA (Non-GAAP Measure)(24,400)(24,800)(7,300)(7,700)

 EX-101.SCH 3 clvr-20220209.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 clvr-20220209_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 clvr-20220209_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, State or Province Entity Address, State or Province Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Entity Emerging Growth Company Entity Emerging Growth Company Soliciting Material Soliciting Material Warrants, each warrant exercisable for one common share at an exercise price of $11.50 Warrant [Member] City Area Code City Area Code Entity Incorporation, Date of Incorporation Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Information [Line Items] Entity Information [Line Items] Entity Address, Address Line Two Entity Address, Address Line Two Local Phone Number Local Phone Number Cover [Abstract] Amendment Description Amendment Description Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Common shares without par value Common Stock [Member] Entity Ex Transition Period Entity Ex Transition Period Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Class of Stock [Domain] Class of Stock [Domain] Document Type Document Type Class of Stock [Axis] Class of Stock [Axis] Entity Registrant Name Entity Registrant Name Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entities [Table] Entities [Table] Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 6 clvr-20220209_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 image_0.jpg begin 644 image_0.jpg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htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover
Feb. 09, 2022
Entity Information [Line Items]  
Document Type 8-K/A
Document Period End Date Feb. 09, 2022
Entity Registrant Name Clever Leaves Holdings Inc.
Entity Incorporation, Date of Incorporation A1
Entity File Number 001-39820
Entity Address, Address Line One 6501 Congress Ave
Entity Address, Address Line Two Suite 240
Entity Address, City or Town Boca Raton
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33487
City Area Code 561
Local Phone Number 634-7430
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001819615
Amendment Description This Amendment No. 1 to the Current Report on Form 8-K (the “Current Report”) filed by Clever Leaves Holdings Inc. (the “Company” or “Clever Leaves”) with the Securities and Exchange Commission on February 9, 2022 (the “Original Form 8-K”) is being filed to:•correct errors reported in the Original Form 8-K concerning the Company’s expected net loss ranges for the quarter and year ended December 31, 2021 and its actual net loss for the quarter and year ended December 31, 2020; •to correct errors reported in the Original Form 8-K reconciling Adjusted EBITDA to the most directly comparable U.S. GAAP measure, net loss; and•re-furnish Exhibit 99.1 (the “Exhibit”), which, as previously furnished, unintentionally omitted the non-GAAP reconciliation table. No other changes have been made to the Original Form 8-K
Amendment Flag true
Common shares without par value  
Entity Information [Line Items]  
Title of 12(b) Security Common shares without par value
Trading Symbol CLVR
Security Exchange Name NASDAQ
Warrants, each warrant exercisable for one common share at an exercise price of $11.50  
Entity Information [Line Items]  
Title of 12(b) Security Warrants, each warrant exercisable for one common share at an exercise price of $11.50
Trading Symbol CLVRW
Security Exchange Name NASDAQ
XML 9 clvr-20220209_htm.xml IDEA: XBRL DOCUMENT 0001819615 2022-02-09 2022-02-09 0001819615 us-gaap:CommonStockMember 2022-02-09 2022-02-09 0001819615 us-gaap:WarrantMember 2022-02-09 2022-02-09 0001819615 true This Amendment No. 1 to the Current Report on Form 8-K (the “Current Report”) filed by Clever Leaves Holdings Inc. (the “Company” or “Clever Leaves”) with the Securities and Exchange Commission on February 9, 2022 (the “Original Form 8-K”) is being filed to:•correct errors reported in the Original Form 8-K concerning the Company’s expected net loss ranges for the quarter and year ended December 31, 2021 and its actual net loss for the quarter and year ended December 31, 2020; •to correct errors reported in the Original Form 8-K reconciling Adjusted EBITDA to the most directly comparable U.S. GAAP measure, net loss; and•re-furnish Exhibit 99.1 (the “Exhibit”), which, as previously furnished, unintentionally omitted the non-GAAP reconciliation table. No other changes have been made to the Original Form 8-K 8-K/A 2022-02-09 Clever Leaves Holdings Inc. A1 001-39820 6501 Congress Ave Suite 240 Boca Raton FL 33487 561 634-7430 false false false false Common shares without par value CLVR NASDAQ Warrants, each warrant exercisable for one common share at an exercise price of $11.50 CLVRW NASDAQ true false 2022-02-09 2022-02-09 EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 3 118 1 false 2 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://cleverleaves.com/role/Cover Cover Cover 1 false false All Reports Book All Reports clvr-20220209.htm clvr-20220209.xsd clvr-20220209_def.xml clvr-20220209_lab.xml clvr-20220209_pre.xml clvr-q4x21prexannouncement.htm http://xbrl.sec.gov/dei/2021 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "clvr-20220209.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "clvr-20220209_def.xml" ] }, "inline": { "local": [ "clvr-20220209.htm" ] }, "labelLink": { "local": [ "clvr-20220209_lab.xml" ] }, "presentationLink": { "local": [ "clvr-20220209_pre.xml" ] }, "schema": { "local": [ "clvr-20220209.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 2, "nsprefix": "clvr", "nsuri": "http://cleverleaves.com/20220209", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvr-20220209.htm", "contextRef": "i1dbd3ce7bcbc451d8cdd03cc9decd7cc_D20220209-20220209", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://cleverleaves.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvr-20220209.htm", "contextRef": "i1dbd3ce7bcbc451d8cdd03cc9decd7cc_D20220209-20220209", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, Date of Incorporation" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common shares without par value" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Warrants, each warrant exercisable for one common share at an exercise price of $11.50" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://cleverleaves.com/role/Cover" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 17 0001819615-22-000038-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001819615-22-000038-xbrl.zip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end